Breaking News, Collaborations & Alliances

Novavax Expands Manufacturing Agreement with SK bioscience

SK will manufacture COVID-19 vaccine containing omicron variant as well as the Novavax COVID-19 vaccine in prefilled syringes.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Novavax has signed agreements with its partner SK bioscience for the manufacturing and supply of a version of the Novavax COVID-19 vaccine (NVX-CoV2373) containing Omicron variant and for the manufacture of the vaccine in prefilled syringes. The companies signed an agreement for the technology transfer of Novavax’ proprietary COVID-19 variant antigen materials so that SK bioscience can manufacture the drug substance targeting COVID-19 variants including the Omicron BA.5 subvariant. &...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters